The trace element selenium has recently attracted attention, particularly because (i) selenocysteine is involved in the active site of various prokaryotic and eukaryotic enzymes, some of which have a role in human health; (ii) selenocysteine incorporation into these proteins is coded by UGA codons; and (iii) as a result, selenocysteine is now considered to be the 21st amino acid in an expanded genetic code. Here, we built recombinant DNA constructs in which expression of the lac'Z gene is driven in Escherichia coli by UGA-directed selenocysteine incorporation. In this system, levels of fl-galactosidase activity are proportionally and specifically related to the presence and concentrations of several specific simple selenium derivatives. The system can thus be used as a sensitive bioassay for their determination. This bioassay is one of a few using recombinant DNA technology to provide a reporter for simple detection of a chemical trace element.
The trace element selenium is an essential component of several enzymes from various prokaryotic and eukaryotic organisms (for a review, see reference 29). These enzymes have been shown to contain selenium in the form of a single selenocysteine residue in the active site of the enzyme (for reviews, see references 28 and 30) . Among the selenocysteine-containing proteins, the best known is the peroxidedestroying enzyme glutathione peroxidase (10, 25) . Selenium, through its involvement with glutathione peroxidase, is one factor in a complex protective antioxidation mechanism that prevents intracellular damage by oxygen-derived free radicals (for a review, see reference 12) . Therefore, researchers in the fields of human medicine and nutrition are studying the relationship of selenium in the diet and blood to free-radical diseases like cancer.
Furthermore, as recently discovered, selenium is also involved, in the form of selenocysteine, in two additional human selenocysteine-containing proteins. The first is the thyroid enzyme 5' deiodinase (1, 2) , which converts thyroxine to the active thyroid hormone. The second is the plasma protein selenoprotein P (14, 23) , which actually contains 10 selenocysteine residues per subunit. Thus, selenium seems to have biochemical functions in addition to those associated with antioxidation and may have a more general role in the maintenance of human health. Low levels of selenium intake have been shown to be associated with only two diseases, Keshan disease (31) and Kachin-Beck disease (16) , both of which occur in China. However, there are claims for a relationship between pronounced or even marginal selenium deficiency and other diseases as well (21) .
In recent years, there have been great interest and excitement in the field of selenium biochemistry and genetics. In-frame TGA codons have been found within the coding sequences of each of the genes that encode selenoproteins, including the Escherichia coli enzyme formate dehydrogenase H (32, 33) and mammalian proteins glutathione peroxidase (6, 20) , 5'-deiodinase (1, 2), and selenoprotein P (14, 23) . It is now known that selenocysteine is encoded by a UGA codon that usually acts as a termination codon. As has been shown in E. coli, several specific genes are involved in this incorporation process (for a review, see reference 3). Of particular importance are the gene seiB, which codes for the SelB protein, and se1C, which codes for tRNASecA. This tRNA is charged with selenocysteine and is thus responsible for selenocysteine incorporation into polypeptides. In addition, a selenium-specific 47-nucleotide-long codon context of the UGA codon in the E. coli formate dehydrogenaseencoding gene (fdhF) has been identified (34) that permits the UGA codon to be read as a selenocysteine codon rather than as a termination codon. This context can form a stem-loop structure (Fig. 1) . Because of the presumed interaction of this stem-loop structure with SelB, the codon context seems to be required for selenocysteine incorporation (13) .
Here we describe our recombinant DNA plasmid constructs, which carry the TGA codon context of the E. coli fdhF gene upstream from the E. coli lac'Z gene (P3-galactosidase gene lacking the first eight codons). We have shown that in E. coli, expression of the lac'Z gene of these constructs is a function of the concentration of the specific simple selenium-containing compound in the medium. Thus, this system can be used as a bioassay for determining the concentrations of several selenium derivatives. As we have shown, it seems to have advantages over procedures currently used for this purpose. 
MATERIALS AND METHODS

Materials
AC-G Ampicillin (100 ,ug/ml) was added to media in which the plasmid-carrying strains were grown.
Bacterial strains and plasmid derivatives. The E. coli strains and the plasmids used in this study are listed in Table  1 . Plasmid pFM20 carries the E. coli fdhF gene (32) . By using the required primers and with plasmid pFM20 as the template, we used the PCR technique to amplify the following two overlapping regions of the fdhF gene flanked by restriction sites HindIII and BamHI: (i) the DNA from nucleotides -1 to +47 (plasmid pRM2) and (ii) the DNA from nucleotides -9 to +47 (plasmid pRM4). The nucleotides are numbered relative to the TGA codon of genefdhF, and the positions are indicated by arrows in Fig. 1E (26) by the plasmid of choice (Table 1) . Single colonies of freshly transformed cells were grown on LB plates for 6 to 8 h and then overnight in M9 medium. On the following day, they were diluted in M9 medium to which a selenium-containing derivative was added; the cells were then grown at 37°C for 2 to 3 h to the mid-log phase (optical density at 600 nm, 0.4 to 0.6). The cells were examined for 3-galactosidase activity in culture aliquots treated with sodium dodecyl sulfate as described by Miller (19) . Labeling and identification of in vivo synthesis of fused gene (27) . Cell lysis and protein extraction were carried out in the presence of 0.2 mM phenylmethylsulfonyl fluoride. Proteins were separated on 7.5% polyacrylamide gels by electrophoresis and detected by autoradiography.
RESULTS
Reporter system for detecting UGA-directed selenocysteine incorporation into a polypeptide. Previously, we had used recombinant DNA technology to construct a reporter system for sensitive detection of UGA readthrough by tryptophanyltRNATrP in E. coli (18) . Here we constructed an analogous system for detection of UGA readthrough by selenocysteinyl-tRNAus'&. We used plasmid pMR1, which carries the fused genes AcI'-lac'I"Z (11, 18) . At the junction of XcI' and lac'I'Z, we inserted regions surrounding the TGA codon of the E. coli fdhF gene; these sequences have been found to permit selenocysteine incorporation into polypeptides (34 In the E. coli MC4100 derivatives ex, genes XcI'-lac'IZ of pMR1 direct the synt polypeptide. This polypeptide was labele nine (lanes 1 of Fig. 2A and B) but nol (lanes 1 of Fig. 2C and D) . On the oth MC4100, the protein product of the gene fi shown). However, quantitative measurements of P-galacto-2 3 4 sidase activity levels revealed that the prfBl mutation did slightly affect the selenium-dependent synthesis of the protein fusion products of both plasmids pRM2 and pRM4 (Fig.   3 ). As shown in Fig. 3 , the level of 3-galactosidase synthesis was selenium independent when directed by pMR1, which has no TGA codon at the XcIT-lac'T'Z junction. In strain MC4100, the 3-galactosidase synthesis level directed by pRM2 was 21% and that directed by pRM4 was 24% (Fig.   3A) ; in strain YN3230, the I-galactosidase synthesis level directed by pRM2 was 25% and that directed by pRM4 was 31% (Fig. 3B) . These values include 2% selenium-indepen-2 3 4 dent I-galactosidase synthesis, which is directed by either pRM2 or pRM4 in strains MC4100 and YN3230 in the absence of selenium or in the AselC derivatives of these strains in the presence of selenium (Fig. 3) . We chose to I ss concentration of selenium in sodium selenate only at very high concentrations (5 x 103 to 106 nM) (Fig. 4C) ; we found no 3-galactosidase activity at all in the presence of selenofrom -1 to +47 is methionine with (data not shown) or without (Fig. 4D ) added from -9 to +47 is methionine. Fig. 1 ).
For comparison, we also determined the concentration of amined, the fused selenium by using each of the described derivatives by the thesis of a 140-kDa well-known atomic absorption spectrophotometric proceId by J`5S]methio-dure. As shown in Fig. 4E, (Fig. 2C,   lanes 2 and 3) . As expected, no radioactive label was incorporated into strain RM1, a AselC derivative of MC4100 (lanes 2 and 3 of Fig. 2B and D) . Thus, the radioactivity in the product of the fused genes of pRM2 and pRM4 is in the form of selenocysteine. In addition, the 140-kDa fused protein was not generated in strain RM1 or YN3230 carrying plasmid pMR1(TGAC) (Fig. 2, lane 4) . This plasmid, like pRM2 and pRM4, carries a C residue after the TGA codon but does not have the rest of the fdhF gene.
Release factor 2 (RF2) competes with natural or mutated UGA suppressors for recognition of the UGA codon (5, 8) ; mutationprfBI in the gene that specifies RF2 increases UGA suppression by a UGA suppressor tRNA and UGA readthrough by tRNATrP (17, 18, 24 (18) . By labeling with [75Se]selenite or [35S]methionine, we found that this mutation had no effect on UGA-directed selenocysteine incorporation into the XcI'-lac'F'Z product of either pRM2 or pRM4 (data not DISCUSSION Recombinant DNA technology has been used to provide reporter systems that can be used generally to detect cisacting elements like regulatory sites or trans-acting elements like proteins, RNA, and other large biological molecules. Here, we used this approach in a new way to measure the presence and concentration of a chemical trace element. We constructed a recombinant DNA reporter system for detection of the essential trace element selenium. We based our system on the findings that (i) selenium is incorporated into polypeptides mainly in the form of selenocysteine and (ii) in E. coli this particular incorporation is permitted by the presence of a TGA codon within a specific codon context (13, 34) . Such a selenocysteine-specific TGA codon context is present in the E. coli fdhF gene, which specifies the selenocysteine-containing enzyme formate dehydrogenase (34) . We inserted these selenium-specifying sequences of the fdhF gene upstream from the E. coli lac'Z gene at the junction of the artificially fused genes XcIF-lac'I"Z located on plasmids pRM2 and pRM4 (Table 1 Selenium-dependent synthesis of ,B-galactosidase directed by plasmids pRM2 and pRM4 in E. coli. E. coli MC4100 and its AselC derivative RM1 (A) and strain YN3230 and its AselC derivative RM2 (B) were transformed by plasmids pMR1, pRM2, pRM4, and pMR1(TGA_). Freshly transformed cells were grown in M9 medium to the mid-log phase in the absence or presence of sodium selenite (final concentration, 1 ,uM). Levels of ,B-galactosidase activity were determined as described previously (18) (for details, see Materials and Methods). The results represent at least three independent experiments. The percentages of 1-galactosidase activity were normalized to the activity directed by plasmid pMR1, which was assigned a value of 100%. plasmids carrying the inserted fdhF sequences directed selenium incorporation into a fused polypeptide product ( Fig. 2A and C) which has selenium-dependent ,B-galactosidase activity (Fig. 3) . Since neither the fused protein nor f-galactosidase activity is obtained in AselC derivatives lacking the gene for tRNA U A, we suggest that selenium is incorporated in the form of selenocysteine (Fig. 2B and D   and 3) . Furthermore, the level of P-galactosidase is proportionally and specifically related to the simple selenium derivatives selenite and selenocysteine (Fig. 4A and B) . Thus, our system of plasmids in appropriate E. coli strains can be used as a bioassay for determining the selenium concentrations in these compounds. Either plasmid pRM2 or plasmid pRM4 can be used. However, we prefer pRM4 in strain YN3230 since it consistently directs slightly higher levels of selenium-dependent ,B-galactosidase activity (Fig. 3) . This is probably because, unlike pRM2, pRM4 carries the 9 additional nucleotides which precede the 47 nucleotides following the TGA of E. coli gene fdhF (Table 1) . Our results corroborate the following two important findings of Zinoni and coworkers (34) : (i) the 47 nucleotides following the UGA codon in the mRNA provide most of the codon context information required for incorporation of selenocysteine into a polypeptide, and (ii) a small stretch of 9 nucleotides upstream from the UGA codon in the fdhF gene may have some role in this process.
It is not understood how the machinery for selenocysteine incorporation may compete with RF2 for recognition of the UGA codon. Our results show that mutation prfBl in the gene that codes for RF2 increases the selenium-dependent P-galactosidase activity directed by either pRM2 or pRM4 by only about 20% (Fig. 3) . In contrast, we have previously shown (18) that this mutation dramatically increases both the selenocysteine-independent UGA suppression by a suppressor tRNA and UGA readthrough by a normal tRNA, probably tRNATrP. Thus, it seems that the presence of the selenium-specific UGA codon context (either by itself or when complexed with tRNAUCA and/or the SelB protein) basically protects this UGA codon from being recognized by RF2. However, even the minimal increase in seleniumdependent 3-galactosidase activity caused by the pafBl mutation reported here suggests that the machinery for selenocysteine incorporation does compete with RF2 at some level. Thus, E. coli MC4100 is less efficient in our bioassay than is strain YN3230, which carries the RF2-inactivating mutation prfBl.
The assays currently available for determining selenium concentrations in various compounds are mainly physical or chemical methods by which the element selenium is determined directly (15, 22) . One of the best methods for this purpose is direct atomic absorption spectrophotometry. By using this method, we measured the atomic absorption of selenium in various simple selenium derivatives, including sodium selenite, sodium selenate, selenocysteine, and selenomethionine, with a selenium dioxide solution as the standard (Fig. 4E ). In comparison with this physical method, our new bioassay, which reflects UGA-directed selenium incorporation, is more specific because it responds to only a few simple selenium derivatives. Probably because sodium selenite (Fig. 4A) and selenocysteine (Fig. 4B) can penetrate the cells and are included in the biochemical pathway of E. coli UGA-directed selenocysteine incorporation, the levels of 3-galactosidase activity are a linear function of low concentrations of these compounds. On the other hand, because of these same criteria, the bioassay cannot be used to measure selenium in either sodium selenate (Fig. 4C) or 5 10 Selenium (nM) . The levels of P-galactosidase activity are presented in Miller units and were determined as described in the legend to Fig. 3 . The results shown are averages of four experiments. In panel E, the concentrations of selenium-containing derivatives (as indicated) were determined by atomic absorption spectrophotometry with a Varians graphite furnace SpectrAA 300 Zeeman atomic spectrophotometer. This spectrophotometer has an automatic background correction system; a solution of 0.1% nitric acid and palladium was used as a chemical modifier (10 ,ul of a 500-i±g/ml concentration). SeO2 (c[Se] = 1.000 0.002 g/liter) was used as the standard selenium solution. For the final estimate of each sample, we used the mean values of three sequential injections of aliquots.
selenomethionine (Fig. 4D) . In addition, the bioassay is about 20 times more sensitive to selenite and selenocysteine than is the atomic absorption spectrophotometric method (Fig. 4) . In addition to the physical methods, two biological assays based on growth rate have been described (7, 9) . They use clostridium strains and therefore require anaerobic conditions for medium preparation and bacterial growth. The methods respond to both selenite and selenocysteine over a concentration range of 10 to 100 nM selenium in these compounds. Thus, in comparison with these bioassays, the one based on recombinant DNA technology and described by us here is simpler and about 20 times more sensitive. The growing implications of selenium in nutrition and medicine support the need for an adequate means of assessing selenium concentrations in biological materials (22) . We offer our recombinant DNA bioassay as an addition to the physical methods currently available.
